Meet Tridentify at the 59th Annual Meeting of the German Society for Transfusion Medicine and Immunohaematology 23-25 Sept

As we all know, the rapid medical progress also requires constant further development in transfusion medicine, therefore, we are delighted to join the DGTI congress in Stuttgart to present our digital SaaS-system. Together with SATO Europe, we will demonstrate the seamless Vein-to-Vein solution. Welcome to Booth no 5.

QTA Tracer System^® is now the world’s First and Only MDR CE-marked Class IIa Temperature Monitoring Solution with Shelf-Life Management for Blood and Transfusion Medicine - uniquely developed for transfusion medicine.

Welcome to schedule a demo. Email: fredrik.radenqrantz@tridentify.com

QTA Tracer System^® has successfully transitioned from the Medical Device Directive (MDD) to achieve formal MDR CE-marking as a Class IIa medical device under the European Union’s rigorous Medical Device Regulation (EU 2017/745).

With this achievement, the QTA Tracer System® secures its position as the first and only temperature monitoring medical solution with shelf-life management worldwide to receive CE-marking according to MDR specifically indicated for transfusion medicine and blood products.

Unmatched Innovation in Blood Safety and Cold Chain Logistics

Unlike traditional data loggers, the QTA Tracer System® acts as an intelligent, real-time Internet of Medical Things (IoMT) solution. By applying custom biological profiles directly to individual blood bags, the system dynamically calculates the actual remaining shelf-life based on real-time exposure to temperature, light, and movement.

This historic MDR CE-marking as a  Class IIa guarantees that healthcare providers, blood banks, and laboratories can fully trust the system's automated quality decisions - safeguarding blood components from donor to patient, or "vein to vein".